|
 |
| home > pmps > winter 2003 > aseptic pharmaceutical manufacturing: the design and validation of water for injection systems |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
In pharmaceutical manufacturing, water is an invaluable resource. It is used in the production, processing and formulation of drug products and is subject to review, monitoring and approval by government bodies. This article contains a conservative approach to evaluating and qualifying water systems used for aseptic pharmaceutical manufacturing as regulated by the US Food and Drug Administration (FDA).
Specification Requirements
As with all manufacturing processes, evaluation of a water system entails three distinct specifications: a user requirement, functional requirement and design requirement. The user requirement defines the quality of water required by the type of pharmaceutical production process. The functional requirements specification describes how the water system will operate. Functional requirements are identified with the goal of identifying system capacity and meeting chemical and microbial limits. Several references are available to aid in the design, development, installation and validation of WFI systems. Most notable are the US Pharmacopoeia Convention (USP) (1), Parenteral Drug Association (2) and ISPE (3). Design requirements detail how the system will be built including system components, construction materials and methods.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Hank Hicks, Validation Director, and David Bosch, Validation Manager, at Pharmaceutical Systems
Hank Hicks is Director of Validation at Pharmaceutical Systems Inc, USA. He has over 15 years' experience specialising in the areas of equipment, critical utilities and process validation. He has managed validation projects for installation of new process equipment, including facility construction/qualification, equipment installation/qualification, and process validation. He has had responsibilities to manage the interface with the FDA during inspections.
David J Bosch is Validation Manager at Pharmaceutical Systems Inc, USA. He has over 10 years' technical experience in equipment, process, and critical utilities validations. He also has experience in calibration of laboratory, manufacturing and data collection equipment, as well as commissioning, cycle development, IQ, OQ and PQ for autoclaves, depyrogenation equipment, washers, temperature controlled units, environmental chambers, laboratory, manufacturing equipment and critical utilities. He has also had direct interface with the FDA during inspections.
|
|
|
|
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
